Other GxP Auditing: Comprehensive Compliance Beyond GMP
Product Introduction
Other GxP Auditing services extend our auditing excellence to critical areas like GCP, GLP, GPvP, and GDP, ensuring holistic compliance across the pharmaceutical lifecycle—from clinical research to pharmacovigilance and distribution. Conducted by specialized subject matter experts, these audits evaluate suppliers and systems against international standards such as ICH-GCP, OECD GLP, GVP Module V, and ISO 13485, providing detailed, regulator-accepted reports for risk mitigation and operational enhancement. Whether for trial sites, labs, or PV systems, our services offer customizable on-site/virtual assessments with client input on auditor selection and report reviews, delivering actionable insights that align with FDA, EMA, and NMPA requirements. With flexible timelines and a focus on for-cause or routine evaluations, we help you qualify partners efficiently, reducing non-compliance risks and supporting seamless global collaborations.
Key Advantages & Features
Our Other GxP Auditing services prioritize expertise, adaptability, and regulatory alignment for superior outcomes. Key highlights include:
|
Advantage/Feature |
Description |
|
Specialized Subject Matter Experts |
Highly qualified auditors with 15+ years in GCP/GLP/GPvP, offering non-conflict options and client-vetted selections for targeted, in-depth assessments. |
|
Detailed & Regulator-Accepted Reports |
Comprehensive packages with CAPA plans and evidence, finalized after client review—widely valid for QPs, regulators, and global stakeholders. |
|
Flexible Audit Customization |
Tailored for specific standards (e.g., ISO 13485 for devices) or focus areas, with hybrid formats to accommodate urgency or remote needs. |
|
Rapid Delivery & Client Involvement |
Reports in 4-5 weeks (expeditable), including pre-finalization feedback to align with internal requirements and minimize revisions. |
|
Global Standards Compliance |
Audits per ICH, OECD, and national guidelines, ensuring harmonization across EU/US/China for export-ready qualifications. |
|
Risk-Based Approach |
Proactive for-cause or routine evaluations with FMEA integration, achieving zero major findings in recent inspections. |
Product Types
Our Other GxP Auditing services are categorized for specialized compliance evaluations, covering key non-GMP domains:
GCP Audits
Full assessments of clinical trial sites, CROs, and investigators for protocol adherence and data integrity.
GPvP Audits
Evaluations of pharmacovigilance systems, including ICSR processing and signal detection for post-marketing safety.
GLP Audits
Compliance checks for non-clinical labs, focusing on study conduct, facilities, and quality assurance per OECD principles.
GDP Audits
Distributor and logistics audits for cold-chain integrity and traceability in supply networks.
ISO 13485 Medical Device Audits
Supplier qualifications for device manufacturing, including risk management and design controls.
Custom GxP Packages
Bundled audits with CAPA closure and ongoing monitoring for integrated lifecycle compliance.
Product Applications
These audits apply across pharmaceutical and related sectors, fortifying operations in diverse scenarios:
Clinical Research Organizations: GCP evaluations for multi-center trials in oncology or rare diseases, ensuring ethical patient recruitment.
Pharmacovigilance Providers: GPvP audits for global PV systems, supporting RMP development and regulatory reporting.
Pre-Clinical Labs: GLP compliance for toxicology studies, vital for IND submissions in biologics development.
Distribution & Logistics Firms: GDP assessments for vaccine cold chains, mitigating risks in international exports.
Medical Device Suppliers: ISO 13485 audits for injectables like insulin pens, aligning with MDR/IVDR requirements.
Integrated R&D Pipelines: For-cause audits for CROs or labs in Phase I-II trials, accelerating pathway to GMP handover.
Comprehensive quality assurance extends beyond manufacturing. DROFEN offers specialized Other GXP auditing services covering Good Laboratory Practice (GLP), Good Clinical Practice (GCP), Good Distribution Practice (GDP), and Good Pharmacovigilance Practice (GVP). Our holistic approach ensures that your entire product lifecycle—from pre-clinical research and clinical trial management to supply chain logistics and post-market safety monitoring—adheres to strict regulatory frameworks. Partner with DROFEN for end-to-end GXP compliance auditing that protects your data integrity and patient safety.